I lead applied AI/ML and data engineering within the Biomedical AI group in R&D at GSK. Joined as Lead Engineer, AI/ML in June 2024; promoted to Director in March 2025.
- Models that inform decisions — built deep-learning models predicting viral evolution, infection incidence and case-accrual timing, and host–immune interactions, used to guide development and lifecycle decisions for a $1B vaccine program; related approaches supported additional programs in the $100M–$500M range. Leads their transition into maintained tools for clinical-development decision-makers.
- Fleming Initiative — leads GSK’s AI/ML and data engineering across all six Grand Challenges; GSK scientific co-lead for Antibiotics and Antifungals, co-developing their scopes of work and scientific plans.
- Teams — built and directly manages a specialist ML engineering team, and repeatedly forms and directs cross-disciplinary teams of 20–30.
- Technical judgment — advises senior R&D leaders on problem framing, method selection, evaluation and build–buy–partner decisions; personally develops and directs work with protein and RNA language models, diffusion approaches, and uncertainty-aware biological-sequence modeling.
- Responsible AI — piloted a project for GSK’s Responsible AI programme and authored a perspective on the work.